Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of ZN-c3 as a Single Agent in Patients With Solid Tumors

NCT04972422 is registered in ClinicalTrials.gov with Zentera Therapeutics HK Limited as lead sponsor.

NCT NCT04972422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04972422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of ZN-c3 as a Single Agent in Patients With Solid Tumors
Lead sponsor
Zentera Therapeutics HK Limited
Phase
Phase 1
Overall status
Unknown status
Start date
July 15, 2021
Completion date
June 30, 2023
Enrollment
38 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors